National University Corporation YOKOHAMA National University (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Yamamoto, Kenta
Kojima, Manabu
Katayama, Ikufumi
Tamaki, Ryo
Abrégé
A non-transitory computer readable medium stores an optical spectrum measurement program to measure, in a single sweep, optical spectra of multiple light rays to be measured. The optical spectrum measurement program is configured to cause a processor to acquire a measurement result of the intensity of a light ray to be measured that is selected one-by-one from among the multiple light rays to be measured, and generate an optical spectrum of each light ray to be measured by associating the light ray to be measured that has been selected during measurement with the acquired measurement result.
G01J 3/32 - Mesure de l'intensité des raies spectrales directement sur le spectre lui-même en étudiant des bandes d'un spectre successivement à l'aide d'un détecteur unique
G01J 3/10 - Aménagements de sources lumineuses spécialement adaptées à la spectrométrie ou à la colorimétrie
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
SUMITOMO CHEMICAL COMPANY, LIMITED (Japon)
Inventeur(s)
Azuma Masaki
Shigematsu Kei
Yoshikawa Kota
Nakayama Hajime
Kaneko Satoru
Yasui Manabu
Kurouchi Masahito
Abrégé
This method for forming a composite oxide pattern includes: a first step of forming, on a substrate 10, a resist film 20 containing hydrogen silsesquioxane (HSQ); a second step of exposing the resist film 20 by using energy rays; a third step of developing the resist film 20 to form a mask 22; a fourth step of depositing a composite-oxide thin film 30 on the mask 22; and a fifth step of removing the mask 22.
H01L 21/363 - Dépôt de matériaux semi-conducteurs sur un substrat, p. ex. croissance épitaxiale en utilisant un dépôt physique, p. ex. dépôt sous vide, pulvérisation
G01N 22/00 - Recherche ou analyse des matériaux par l'utilisation de micro-ondes ou d'ondes radio, c.-à-d. d'ondes électromagnétiques d'une longueur d'onde d'un millimètre ou plus
G01N 21/3581 - CouleurPropriétés spectrales, c.-à-d. comparaison de l'effet du matériau sur la lumière pour plusieurs longueurs d'ondes ou plusieurs bandes de longueurs d'ondes différentes en recherchant l'effet relatif du matériau pour les longueurs d'ondes caractéristiques d'éléments ou de molécules spécifiques, p. ex. spectrométrie d'absorption atomique en utilisant la lumière infrarouge en utilisant la lumière de l'infrarouge lointainCouleurPropriétés spectrales, c.-à-d. comparaison de l'effet du matériau sur la lumière pour plusieurs longueurs d'ondes ou plusieurs bandes de longueurs d'ondes différentes en recherchant l'effet relatif du matériau pour les longueurs d'ondes caractéristiques d'éléments ou de molécules spécifiques, p. ex. spectrométrie d'absorption atomique en utilisant la lumière infrarouge en utilisant un rayonnement térahertz
Kanagawa Institute of Industrial Science and Technology (Japon)
Inventeur(s)
Sato, Moritoshi
Kuwasaki, Yuto
Nakajima, Takahiro
Abrégé
The present invention provides a set of Affibody and photoreceptor protein, wherein the Affibody and the photoreceptor protein form a complex in a manner dependent on light at a wavelength of 600 to 750 nm.
National University Corporation YOKOHAMA National University (Japon)
Kanagawa Institute of Industrial Science and Technology (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Yan, Lei
Abrégé
Provided are a method of producing hair follicle mesenchymal cells whose number has been expanded and whose hair regeneration abilities have been recovered, and a use thereof. The method of producing expanded hair follicle mesenchymal cells includes a main step of culturing hair follicle mesenchymal cells adhered to a substrate surface from a confluent state without passaging the cells. The main step includes culturing the hair follicle mesenchymal cells to make the cells proliferate further from the confluent state until the proliferated hair follicle mesenchymal cells are stacked to form cell layers including two or more stacked layers in at least part of the substrate surface.
A61K 35/28 - Moelle osseuseCellules souches hématopoïétiquesCellules souches mésenchymateuses de toutes origines, p. ex. cellules souches dérivées de tissu adipeux
A61P 17/14 - Médicaments pour le traitement des troubles dermatologiques pour le traitement de la calvitie ou de l'alopécie
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
INSTITUTE OF SCIENCE TOKYO (Japon)
UNIVERSITY OF MIYAZAKI (Japon)
FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION AT KOBE (Japon)
Inventeur(s)
Ajioka Itsuki
Muraoka Takahiro
Miyauchi Chikako
Kitamura Kazuo
Nishimura Hideo
Abrégé
The present invention addresses the problem of providing a novel method for treating cerebral infarction that does not depend on cell transplantation. Provided is a fusion peptide obtained by linking adrenomedullin or an active fragment thereof with a self-assembling peptide.
A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides
A61K 47/64 - Conjugués médicament-peptide, médicament-protéine ou médicament-acide polyaminé, c.-à-d. l’agent de modification étant un peptide, une protéine ou un acide polyaminé lié par covalence ou complexé à un agent thérapeutiquement actif
A61L 27/54 - Matériaux biologiquement actifs, p. ex. substances thérapeutiques
A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
C07K 7/06 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 5 à 11 amino-acides
C07K 7/08 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 12 à 20 amino-acides
C07K 14/47 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains provenant de vertébrés provenant de mammifères
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
INSTITUTE OF SCIENCE TOKYO (Japon)
Inventeur(s)
Ajioka Itsuki
Muraoka Takahiro
Miyauchi Chikako
Yaguchi Atsuya
Abrégé
The present invention addresses the problem of providing a novel method for easily removing gel under physiological conditions without using protease. Provided is a modified peptide having gel degradation activity and including at least one modified core peptide comprising an amino acid sequence represented by formula I: Xaa-Yaa-Zaa-Yaa-Xaa-Yaa-Zaa-Yaa-Xaa (in the formula, Xaa is independently Ile or Met; Yaa is independently Asp, Glu, Lys, or Arg; and Zaa is independently Ala or Gly). A nitrogen atom constituting any one or more peptide bonds constituting the modified core peptide has a substituent.
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Abrégé
Provided is a dermal papilla cell activation composition for effectively activating dermal papilla cells. The dermal papilla cell activation composition contains oxytocin and/or an oxytocin receptor agonist. The dermal papilla cell activation composition may be a topical skin formulation, a topical scalp formulation, a composition for hair growth or hair restoration, a culture medium, or an additive for a culture medium.
A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
A61K 8/64 - ProtéinesPeptidesLeurs dérivés ou produits de dégradation
A61K 31/551 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à sept chaînons, p. ex. azélastine, pentylènetétrazole ayant deux atomes d'azote comme hétéro-atomes d'un cycle, p. ex. clozapine, dilazèpe
A61K 45/00 - Préparations médicinales contenant des ingrédients actifs non prévus dans les groupes
A61P 17/14 - Médicaments pour le traitement des troubles dermatologiques pour le traitement de la calvitie ou de l'alopécie
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
A61Q 7/00 - Préparations pour modifier la pousse des cheveux ou des poils
C07K 7/06 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 5 à 11 amino-acides
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
C12Q 1/6876 - Produits d’acides nucléiques utilisés dans l’analyse d’acides nucléiques, p. ex. amorces ou sondes
9.
PARTITION WALL FOR FORMING LIPID BILAYER MEMBRANE AND LIPID BILAYER MEMBRANE FORMING DEVICE INCLUDING SAME, AND METHOD FOR FORMING LIPID BILAYER MEMBRANE USING SAME
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
THE UNIVERSITY OF TOKYO (Japon)
MAQSYS CO., LTD. (Japon)
Inventeur(s)
Mimura, Hisatoshi
Takamori, Sho
Takeuchi, Shoji
Osaki, Toshihisa
Nakao, Kenji
Abrégé
Disclosed is a means capable of enhancing the efficiency of formation of a lipid bilayer membrane and the efficiency of introduction of a membrane protein to a lipid bilayer membrane compared with lipid bilayer membrane formation by a conventional droplet contact method. The partition wall for forming a lipid bilayer membrane has a through hole in which a planar lipid bilayer membrane is formed. The planar shape of the through hole has at least a linear portion, and the lipid bilayer membrane formed also has a linear portion. Also provided are: a lipid bilayer membrane formation device having the partition wall for forming a lipid bilayer membrane; a method for forming a lipid bilayer membrane using the device; and a lipid bilayer membrane formed in a through-hole portion of a partition wall, wherein the peripheral edge has a linear portion.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
KEIO UNIVERSITY (Japon)
MOTION LIB, INC. (Japon)
NICHIBEIKAI MEDICAL CORPORATION (Japon)
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
Inventeur(s)
Shimono Tomoyuki
Matsunaga Takuya
Ohnishi Kouhei
Mizoguchi Takahiro
Yukinari Tsuyoshi
Ui Megumi
Abrégé
[Problem] To more appropriately support diagnosis when diagnosis accompanied by a medical action from a remote place is performed. [Solution] A remote medical support system 1 comprises a work mechanism 25, an operation mechanism 15, an operation control unit 313, and a presentation unit 314. The work mechanism 25 is a mechanism for performing a medical action including palpation of a subject. The operation mechanism 15 is a mechanism for receiving a remote operation for the work mechanism 25 from an operator. The operation control unit 313 controls the operation of the work mechanism 25 according to the remote operation received by the operation mechanism 15, and transmits the reaction force applied to the work mechanism 25 in response to the contact of the work mechanism 25 with the subject to the operator via the operation mechanism 15 as a tactile force. The presentation unit 314 presents, to the operator, support information for supporting diagnosis based on the medical practice acquired on the work mechanism side.
A61B 5/00 - Mesure servant à établir un diagnostic Identification des individus
B25J 3/00 - Manipulateurs de type à commande asservie, c.-à-d. manipulateurs dans lesquels l'unité de commande et l'unité commandée exécutent des mouvements correspondants dans l'espace
11.
ESTABLISHMENT OF THERAPY AND DIAGNOSIS FOR ALLERGIC DISEASES THROUGH CONTROL OF IMMUNOGLOBULIN-BINDING PROTEIN
Kanagawa Institute of Industrial Science and Technology (Japon)
University of Tsukuba (Japon)
Metagen, Inc. (Japon)
Inventeur(s)
Fukuda, Shinji
Nakato, Gaku
Obana, Nozomu
Furukawa, Risako
Abrégé
Determination of the mechanism of allergy development in which a bacterium of the family Lachnospiraceae, which is an enteric bacterium, including Ruminococcus gnavus is involved and developing a method for preventing or treating allergies by intervening in the mechanism. Since the Ibp protein from a bacterium of the family Lachnospiraceae is involved in development of allergies, allergic reactions occurring in vivo can be prevented by administration or induction of in vivo production of a substance that binds to the Ibp protein.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
SUMITOMO CHEMICAL COMPANY, LIMITED (Japon)
Inventeur(s)
Azuma, Masaki
Shigematsu, Kei
Lee, Koomok
Abrégé
A method of manufacturing a Hall element includes: forming a perovskite-type magnetic material layer on a substrate having a perovskite structure and composed of a compound having a lattice constant of 3.90-3.97 Å in pseudocubic notation; forming an insulator layer containing SrTiO3 on the perovskite-type magnetic material layer; and forming a Hall element containing InSb, GaAs, InAs or a solid solution thereof on the insulator layer.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
KEIO UNIVERSITY (Japon)
MOTION LIB, INC. (Japon)
Inventeur(s)
Shimono Tomoyuki
Matsunaga Takuya
Takano Shunya
Ohnishi Kouhei
Nakamura Masaya
Yagi Mitsuru
Mima Yuichiro
Yamanouchi Kento
Mizoguchi Takahiro
Abrégé
[Problem] To more appropriately grasp the situation of a treatment in a medical procedure. [Solution] This medical device 1 comprises a slave-side actuator 212, an operation control unit 311, a state specification unit 313, and a situation determination unit 314. The slave-side actuator 212 causes a treatment mechanism 60 to perform a treatment on a patient. The operation control unit 311 calculates a control parameter relating to a force-tactile sensation on the basis of information relating to a position detected in the course of the treatment and controls the operation of the slave-side actuator 212 on the basis of the control parameter. The state specification unit 313 calculates a state parameter indicating the state of a treatment target site 40 with which the treatment mechanism 60 is in contact on the basis of the information relating to the position detected in the course of the treatment. The situation determination unit 314 performs a determination based on the control parameter and the state parameter, and thereby detects when the treatment by the treatment mechanism 60 has reached a prescribed situation.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
METAGEN, INC. (Japon)
METAGEN THERAPEUTICS, INC. (Japon)
Inventeur(s)
Fukuda Shinji
Nakato Gaku
Nakahara Taku
Abrégé
The present invention addresses the problem of developing a substance capable of preventing or treating allergic diseases, and a pharmaceutical composition containing said substance, on the basis of the previous finding that allergic disease reactions occurring in a living body can be prevented by a substance that binds to an Ibp protein of bacteria belonging to the family Lachnospiraceae. The inventors of the present invention have found that an antibody or antibody derivative is created as a substance which, instead of direct binding to IgE, binds to a region important for binding to IgE in an Ibp protein produced by bacteria belonging to the family Lachnospiraceae, which are intestinal bacteria associated with allergic diseases, and a pharmaceutical composition for preventing or treating allergic diseases, containing said antibody or antibody derivative, can be provided.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Matsumoto Akira
Barthelmes Kevin
Matsumoto Hiroko
Abrégé
The purpose of the present invention is to optimize washing of a microneedle taken out from a mold while securing safety in a living body. This method for manufacturing a microneedle comprises: a step for preparing a mold in which a cavity corresponding to the structure of a microneedle is formed; a step for preparing a pre-gel solution containing a monomer mixture; a step for injecting a pre-gel solution into a prescribed part of the mold; a step for polymerizing the monomer mixture in the pre-gel solution in the mold to form a gel composition; a step for taking out the obtained molded body from the mold; a step for washing the molded body taken out from the mold; and a step for drying the molded body after washing. The step for washing the molded body includes immersing the molded body in a mixed solution of methanol and water.
A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Sato Moritoshi
Kawano Fuun
Otabe Takahiro
Abrégé
[Problem] The present invention addresses the problem of providing a photoswitch protein that can control binding and dissociation of protein more efficiently than conventional photoswitch proteins. [Solution] This photoswitch protein is formed of a single polypeptide, unlike conventional photoswitch proteins formed of two separate proteins. More specifically, a switch protein according to the present invention is, for example, a protein in which the C-terminal of the following protein (a) and the N-terminal of the following protein (b) are directly or indirectly linked. (a) A protein having an amino acid sequence that has a sequence identity of 80% or more with respect to an amino acid sequence resulting from deletion of X-number of consecutive amino acid residues from the C-terminal residue toward the N-terminal of an amino acid sequence indicated by SEQ ID NO. 1 or SEQ ID NO. 36. X is an integer of 0-6. (b) A protein having an amino acid sequence that has a sequence identity of 80% or more with respect to an amino acid sequence resulting from deletion of Y-number of consecutive amino acid residues from the N-terminal residue toward the C-terminal of an amino acid sequence represented by SEQ ID NO. 1 or SEQ ID NO. 36. Y is an integer of 0-55.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
SUMITOMO CHEMICAL COMPANY, LIMITED (Japon)
Inventeur(s)
Azuma Masaki
Shigematsu Kei
Ito Takuma
Abrégé
1-xx33, where A is Co or Mn, and x satisfies 0.05 ≦ x < 0.25. The first electrode and the second electrode are disposed such that an electric field is generated in a direction parallel to the thin-film when a voltage is applied between the first electrode and the second electrode.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (Japon)
Inventeur(s)
Itoh Michiko
Matsumoto Hiroko
Kanai Sayaka
Matsumoto Akira
Abrégé
Provided are: a sugar responsive gel that is produced by a photopolymerization reaction and that has an accurate response to a change in sugar concentration; and a drug delivery device using said sugar responsive gel. The present embodiment relates to a sugar responsive gel including a polymerization reaction product which is a mixture including (A) a prescribed gelling agent, (B) a phenylboronic acid-based monomer represented by a prescribed formula, (C) a hydroxyl-based monomer represented by a prescribed formula, (D) a crosslinking agent, and (E) a photopolymerization initiation agent, wherein: the molar ratio of (the total of component (A) and component (B))∶component (C) is within the range of 4.5∶1 to 6.5∶1; and the proportion of the crosslinking agent relative to the total of component (A), component (B), and component (C) is 1.5-4 mol%.
A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
A61K 45/00 - Préparations médicinales contenant des ingrédients actifs non prévus dans les groupes
A61K 47/18 - AminesAmidesUréesComposés d’ammonium quaternaireAcides aminésOligopeptides ayant jusqu’à cinq acides aminés
A61K 47/24 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant des atomes autres que des atomes de carbone, d'hydrogène, d'oxygène, d'halogènes, d'azote ou de soufre, p. ex. cyclométhicone ou phospholipides
A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
20.
ACTION FOR SUPPRESSING ANY INCREASE IN BODY WEIGHT BY AQUEOUS EXTRACT OF NANNOCHLOROPSIS ALGAE
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NIHON FILTER CO., LTD. (Japon)
Inventeur(s)
Yano Atsushi
Umezu Akira
Mitome Kanoko
Sasaki Yuko
Kamei Asuka
Shimada Kosuke
Shinozaki Fumika
Shimojima Mie
Ohta Hiroyuki
Iwai Masako
Ihara Yuta
Abrégé
The present invention provides a novel application for Nannochloropsis algae. Specifically, an aqueous extract of Nannochloropsis algae is used in suppressing any increase in body weight or inhibiting any acceleration in synthesis of cholesterol.
A23L 33/20 - Diminution de la valeur nutritiveProduits diététiques avec valeur nutritive réduite
A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
A61K 31/683 - Diesters d'acide du phosphore avec deux composés hydroxyle, p. ex. phosphatidylinositols
A61P 1/16 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des troubles de la vésicule biliaire ou du foie, p. ex. protecteurs hépatiques, cholagogues, cholélitholytiques
A61P 3/00 - Médicaments pour le traitement des troubles du métabolisme
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Sato Moritoshi
Nakajima Takahiro
Abrégé
The present invention addresses the problem of providing an RpBphP1 mutant and an RpPpsR2 mutant that are modified so as to enable control of binding and unbinding therebetween with certainty through photoirradiation and blocking of near infrared light. More specifically, the present invention pertains to a protein set that comprises two proteins that bind with each other when being irradiated with near infrared light. The protein set is a set of an RpBphP1 mutant and the wild type RpPpsR2, a set of the wild type RpBphP1 and an RpPpsR2 mutant, or a set of the RpBphP1 mutant and the RpPpsR2 mutant. As compared to the binding of the wild type RpBphP1 and the wild type RpPpsR2, the binding among the protein set is weaker in a dark place and/or is stronger when being irradiated with near infrared light.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Yahagi Tsukaho
Abrégé
Provided are: an embedding and fixation composition that enables clear visualization of a microstructure of a solid material formed of a light element such as graphite and boron nitride and thereby improving the visibility thereof, in observation using an electron microscope or the like; and an observation method with an electron microscope or the like using the embedding and fixation composition. According to the present invention, a water-soluble polymer such as polyvinyl alcohol and a water-soluble heavy metal salt such as phosphotungstic acid are dissolved in water to obtain a liquid composition. A solid material is impregnated with the liquid composition, which is then solidified, to have a microstructure embedded and fixed. Then, the microstructure is observed using an electron microscope or the like.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
KEIO UNIVERSITY (Japon)
Inventeur(s)
Shimono Tomoyuki
Takano Shunya
Hasegawa Atsushi
Masak Katsunori
Nakada Hideo
Fukunaga Koichi
Aomori Tohru
Nishie Miyuki
Hakamata Jun
Abrégé
[Problem] To provide appropriate assistance for medical workers in relation to the use of a medical device by a patient. [Solution] A medical assessment system S comprises an assessment data measurement unit 112, an assessment execution unit 212, and a result presentation unit 213. The assessment data measurement unit 112 measures time-series data of a physical quantity of a medical device during an inhalation action by a user using a medical device. The assessment execution unit 212 uses, as a reference, time-series data of the physical quantity in a case where an inhalation action is performed through proper use of the medical device, compares the time-series data used as the reference and the time-series data of the physical quantity measured by the assessment data measurement unit 112, and makes a determination as to whether or not the inhalation action was performed by the user with proper use of the medical device. The result presentation unit 213 presents an assessment result provided by the assessment execution unit 212.
G16H 40/40 - TIC spécialement adaptées à la gestion ou à l’administration de ressources ou d’établissements de santéTIC spécialement adaptées à la gestion ou au fonctionnement d’équipement ou de dispositifs médicaux pour la gestion d’équipement ou de dispositifs médicaux, p. ex. pour planifier la maintenance ou les mises à jour
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Sato, Moritoshi
Kuwasaki, Yuto
Nakajima, Takahiro
Abrégé
The present invention provides a set of an affibody and a photoreceptor protein, in which the affibody and the photoreceptor protein form a complex in a light-dependent manner at wavelengths of 600-750 nm.
C07K 14/31 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Micrococcaceae (F) provenant de Staphylococcus (G)
C07K 14/195 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries
25.
METHOD FOR MANUFACTURING HALL ELEMENT, AND MAGNETIC MEMORY ELEMENT
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Azuma Masaki
Shigematsu Kei
Lee Koomok
Abrégé
33 on the perovskite-type magnetic layer 14; and a step for forming, on the insulating layer 16, a Hall element 18 including InSb, GaAs, InAs, or a solid solution thereof.
PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Sawamoto Kazunobu
Kaneko Naoko
Nakajima Chikako
Ohno Yuya
Ajioka Itsuki
Muraoka Takahiro
Abrégé
Provided is a technique capable of promoting the migration of neurons. This neuronal migration promoter comprises a self-assembling peptide and a composition fused to the self-assembling peptide, and the composition includes at least one among a cadherin extracellular domain and a heparan sulfate proteoglycan extracellular domain. In addition, a method for promoting the migration of neurons comprises a step for bringing a self-assembling peptide and a composition fused to the self-assembling peptide into contact with neurons, and the composition includes at least one among a cadherin extracellular domain and a heparan sulfate proteoglycan extracellular domain.
C07K 7/08 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 12 à 20 amino-acides
C07K 14/00 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
C07K 14/435 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'animauxPeptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant d'humains
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Yan, Lei
Abrégé
Provided are: a method for producing hair follicle mesenchymal cells of which the number is increased and the hair regeneration capability is restored; and a use of the hair follicle mesenchymal cells. The method for producing proliferated hair follicle mesenchymal cells includes a main step for culturing hair follicle mesenchymal cells that have been adhered onto the surface of a substrate from a confluent state without the need to perform subculturing, in which the main step includes further proliferating the hair follicle mesenchymal cells from the confluent state, thereby culturing the hair follicle mesenchymal cells until the proliferated hair follicle mesenchymal cells are layered on at least a portion of the surface of the substrate to form at least two cell layers.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Nakajima, Akira
Ito, Takuro
Matsushita, Sachiko
Isobe, Toshihiro
Sunada, Kayano
Abrégé
Provided are a complex oxide ceramic having high antiviral activity, a functional material, and an article provided with the complex oxide ceramic and/or the functional material. The complex oxide ceramic according to one aspect of the present invention is a complex oxide ceramic containing cerium and molybdenum and having antiviral activity. The functional material according to one aspect of the present invention is also a functional material including the complex oxide ceramic mixed with a photocatalyst and/or an antibacterial effect. The article according to one aspect of the present invention is an article having the complex oxide ceramic and/or the functional material on at least a part of the surface thereof.
C04B 35/50 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base de composés de terres rares
A61L 2/232 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des substances chimiques des substances solides, p. ex. des granules, des poudres, des blocs, des comprimés en couches ou revêtues
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Imai, Keiichi
Fukuda, Junji
Kageyama, Tatsuto
Nanmo, Ayaka
Abrégé
A cell transplanting kit includes a transplant including a cell group and a cell transplanting device. The cell transplanting device includes a needle-shaped portion that extends in a shape of a tube, and an aspiration portion configured to aspirate an interior of the needle-shaped portion. The needle-shaped portion is configured to attract the transplant by aspiration by the aspiration portion and take the transplant into the interior. The aspiration portion is configured to create an aspiration pressure in a range of −100 kPa to −0.1 kPa. The transplant includes a protection portion in a form of a gel covering at least a part of the cell group. The transplant has an outer diameter that is greater than or equal to a minimum value of the inner diameter of the needle-shaped portion. The protection portion has a jelly strength of greater than or equal to 100 g.
NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Muraoka, Takahiro
Yaguchi, Atsuya
Ajioka, Itsuki
Watanabe, Go
Abrégé
An object is to provide a peptide gelling agent which gels under physiological conditions and which has a relatively short chain length, and a sustained-release gel based on it. Provided is a hydrogelling self-assembling peptide comprising one or two core peptides consisting of an amino acid sequence represented by the following formula: Xaa-Yaa-Zaa-Yaa-Xaa-Yaa-Zaa-Yaa-Xaa, wherein Xaa is independently Ile or Met, Yaa is independently Asp, Glu, Lys, or Arg, and Zaa is independently Ala or Gly, and wherein the full length of the amino acid sequence constituting said self-assembling peptide is 25 amino acids or less.
A61K 47/42 - ProtéinesPolypeptidesLeurs produits de dégradationLeurs dérivés p. ex. albumine, gélatine ou zéine
C07K 14/50 - Facteur de croissance des fibroblastes [FGF]
A61P 25/28 - Médicaments pour le traitement des troubles du système nerveux des troubles dégénératifs du système nerveux central, p. ex. agents nootropes, activateurs de la cognition, médicaments pour traiter la maladie d'Alzheimer ou d'autres formes de démence
A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Sunada Yusuke
Ito Tatsuyoshi
Abrégé
[Problem] To provide a hydrogen storage means having excellent points such as being free of precious metals, having high efficiency, being safe, etc. [Solution] Provided is a hydrogen storage composition that, in several embodiments, contains a siloxane skeleton and includes a hydrogen storage material, having an aromatic group, and a nickel-supporting catalyst. In several preferable embodiments, the hydrogen storage material is a silicone oil, which is a polymer that contains a siloxane skeleton and includes an aromatic group on a side chain. Furthermore, a hydrogen storage method is provided, in several embodiments, in which the hydrogen storage composition and hydrogen are brought into contact to add the hydrogen to the aromatic group of the hydrogen storage material.
B01J 31/28 - Catalyseurs contenant des hydrures, des complexes de coordination ou des composés organiques contenant en outre des composés métalliques inorganiques non prévus dans les groupes du groupe du platine, du cuivre ou du groupe du fer
C08K 3/00 - Emploi de substances inorganiques en tant qu'adjuvants
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
UNIVERSITY OF TSUKUBA (Japon)
METAGEN, INC. (Japon)
Inventeur(s)
Fukuda Shinji
Nakato Gaku
Obana Nozomu
Furukawa Risako
Abrégé
The present invention addresses the problem of revealing a symptom onset mechanism of allergies in which bacteria belonging to the family Lachnospiraceae including Ruminococcus gnavus (R. gnavus) which is an enteric bacterium is involved, and developing a means for preventing or treating allergies by intervening in the mechanism. As a result of conducting thorough investigation, the present inventors have found that Ibp protein from bacteria belonging to the family Lachnospiraceae is involved in the onset of allergies, and have shown that said problem can be solved. Specifically, it is possible to prevent allergic reactions occurring in a body by administering, to the body, or inducing production of, within the body, a substance that binds to Ibp protein from bacteria belonging to the family Lachnospiraceae.
C12Q 1/02 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des micro-organismes viables
G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides
C07K 14/195 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
KEIO UNIVERSITY (Japon)
Inventeur(s)
Shimono, Tomoyuki
Asai, Hiroshi
Ohnishi, Kouhei
Matsunaga, Takuya
Kobayashi, Hironao
Nakamura, Masaya
Yagi, Mitsuru
Abrégé
A medical apparatus includes a treatment mechanism, a slave actuator, an operation control unit, and a parameter acquisition unit. The treatment mechanism is used for treating a patient. The slave actuator causes the treatment mechanism to perform the treatment. The operation control unit calculates the control parameters related to the force tactile sensation, based on the information about the position that is detected along with the treatment and controls the operation of the slave actuator for causing the treatment mechanism to perform the treatment, based on the control parameters related to the force tactile sensation. The parameter acquisition unit acquires the control parameters related to the force tactile sensation.
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Anakama, Riki
Hidaka, Tatsuhiko
Abrégé
This method for producing a cell aggregate comprises: plating epithelial cells and mesenchymal cells; and co-culturing the epithelial cells and the mesenchymal cells to form a cell aggregate having a hair regeneration ability. The co-culturing includes a matrix process for keeping the epithelial cells and the mesenchymal cells in a culture solution having dispersed therein type-I collagen or fibronectin.
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
C12N 5/077 - Cellules mésenchymateuses, p. ex. cellules osseuses, cellules de cartilage, cellules stromales médulaires, cellules adipeuses ou cellules musculaires
C12Q 1/02 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des micro-organismes viables
35.
DRUG DELIVERY DEVICE AND METHOD FOR PRODUCING SAME
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (Japon)
Inventeur(s)
Miyazaki Takuya
Itoh Michiko
Matsumoto Hiroko
Kanai Sayaka
Matsumoto Akira
Abrégé
The present invention provides a microneedle-type drug delivery device that has sufficient mechanical strength for puncturing. A microneedle 10 has a base part 100 and at least one needle 110 supported by the base part 100. The needle 110 can carry a drug and contains a gel composition that has permeability with respect to the drug. The base part 100 has a porous body that serves as a reservoir of the drug carried by the needle 110.
A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
A61K 9/00 - Préparations médicinales caractérisées par un aspect particulier
A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
A61P 3/10 - Médicaments pour le traitement des troubles du métabolisme de l'homéostase du glucose de l'hyperglycémie, p. ex. antidiabétiques
36.
Fracture toughness testing machine and fracture toughness test method
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
JP STEEL PLANTECH CO. (Japon)
Inventeur(s)
Hosoi, Atsushi
Kawada, Hiroyuki
Harada, Kazuki
Jespersen, Kristine Munk
Abrégé
A fracture toughness testing machine evaluates fracture toughness of a specimen in pure mode. The testing machine includes: a testing-load applying device for applying a predetermined testing load to the specimen, in which the stresses are present; and a cancelling-load applying device for applying a cancelling load to the specimen to cancel the stresses therein. The cancelling-load applying device includes: a pressing-force applying portion that applies a pressing force to the specimen as the canceling load; and a pressing-force determining portion that determines magnitude of the force. The pressing-force determining portion calculates the magnitude of the force using pre-stored equations so that an energy release rate related to in-plane shear mode crack deformation becomes zero.
G01N 3/08 - Recherche des propriétés mécaniques des matériaux solides par application d'une contrainte mécanique par application d'efforts permanents de traction ou de compression
G01N 3/24 - Recherche des propriétés mécaniques des matériaux solides par application d'une contrainte mécanique en appliquant des efforts permanents de cisaillement
G01N 19/04 - Mesure de la force d'adhérence entre matériaux, p. ex. du ruban adhésif, d'un revêtement
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Yamaguchi Takeo
Sankar Sasidharan
G.M. Anilkumar
Kuroki Hidenori
Miyanishi Shoji
Tamaki Takanori
Abrégé
222P. The method has a step (I) for immersing a nickel substrate in an iron ion solution, and a step (II) for phosphidation of the nickel substrate after immersion.
C25B 1/04 - Hydrogène ou oxygène par électrolyse de l'eau
C25B 9/00 - Cellules ou assemblages de cellulesÉléments de structure des cellulesAssemblages d'éléments de structure, p. ex. assemblages d'électrode-diaphragmeCaractéristiques des cellules relatives aux procédés
C25B 9/23 - Cellules comprenant des électrodes fixes de dimensions stablesAssemblages de leurs éléments de structure avec des diaphragmes comprenant des membranes échangeuses d'ions dans ou sur lesquelles est incrusté du matériau pour électrode
C25B 11/052 - Électrodes comportant un substrat et un ou plusieurs revêtements électro-catalytiques
C25B 11/091 - Électrodes comportant des électro-catalyseurs sur un substrat ou un support caractérisées par le matériau électro-catalytique formé d’au moins un élément catalytique et d’au moins un composé catalytiqueÉlectrodes comportant des électro-catalyseurs sur un substrat ou un support caractérisées par le matériau électro-catalytique formé de plusieurs éléments catalytiques ou composés catalytiques
38.
Measurement instrument and method for measuring target substance using same
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Yamada, Tetsuya
Osaki, Toshihisa
Mimura, Hisatoshi
Sugiura, Hirotaka
Takeuchi, Shoji
Abrégé
The present invention provides a measuring device which includes: a first container and a second container that are arranged adjacent to each other; and a partition wall provided between the first and second containers, the partition wall having a through hole(s) for forming a lipid bilayer(s). In this measuring device, a gas flow path(s) having a hydrophobic surface is/are formed in at least one of the first and second containers; the gas flow path(s) has/have an inlet and an outlet; the inlet and the outlet each communicate with the exterior of the measuring device; the gas flow path(s) open(s) into the container in which it/they is/are formed; and a gas flowing in the gas flow path(s) contacts the droplet filled in the container.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Sunada Yusuke
Ito Tatsuyoshi
Abrégé
[Problem] To provide a material utilizable as a catalyst for reactions including hydrosilylation. [Solution] Provided is a composite comprising a transition metal complex and a support on which the transition metal complex is supported, wherein the support comprises a silicon-based material having an Si-H group, the silicon-based material being selected from the group consisting of silicon-based polymers, silicon-based ceramics, and silicon metal. Also provided is a composite comprising a transition metal and a support on which the transition metal is supported, wherein the support comprises a silicon-based material having an Si-H group, the silicon-based material being selected from the group consisting of silicon-based polymers, silicon-based ceramics, and silicon metal.
National University Corporation Yokohama National University (Japon)
Kanagawa Institute of Industrial Science and Technology (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Shimizu, Akihiro
Nakajima, Rikuma
Anakama, Riki
Abrégé
Provided is a hair follicle germ capable of forming a hair shaft-like structure in vitro simply and within a short period of time. A method of producing a hair follicle germ includes: inoculating epithelial cells and mesenchymal cells; maintaining the epithelial cells and the mesenchymal cells in a culture solution in which (a) laminin and entactin, and/or (b) type IV collagen is dispersed; and co-culturing the epithelial cells and the mesenchymal cells in a culture solution to form a hair follicle germ.
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
41.
POLYGLYCEROL, COMPLEX GEL COMPOSITION CONTAINING SAID POLYGLYCEROL, DRUG DELIVERY MICRO-NEEDLE INCLUDING SAID COMPLEX GEL COMPOSITION, AND METHODS FOR PRODUCING SAME
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (Japon)
Inventeur(s)
Matsumoto Akira
Miyazaki Takuya
Abrégé
The present invention achieves both sufficient mechanical strength for puncturing the skin, and high drug-releasing ability after puncturing the skin. A micro-needle 10 has a base part 100 and at least one needle 110 supported by the base part 100. In one mode of the present invention, the needle 110 contains a complex gel composition including a polyglycerol and a copolymer including a phenylboronate-based monomer unit, is capable of holding a drug, and has permeability with respect to the drug.
C08G 65/26 - Composés macromoléculaires obtenus par des réactions créant une liaison éther dans la chaîne principale de la macromolécule à partir d'éthers cycliques par ouverture d'un hétérocycle à partir d'éthers cycliques et d'autres composés
C08G 65/331 - Polymères modifiés par post-traitement chimique avec des composés organiques contenant de l'oxygène
C08G 81/02 - Composés macromoléculaires obtenus par l'interréaction de polymères en l'absence de monomères, p. ex. polymères séquencés au moins un des polymères étant obtenu par des réactions ne faisant intervenir que des liaisons non saturées carbone-carbone
A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
CANON KABUSHIKI KAISHA (Japon)
Inventeur(s)
Azuma, Masaki
Sakai, Yuki
Kojima, Takahiro
Abrégé
The present invention aims to obtain a resin composition with low thermal expansion property by suppressing functional deterioration in negative thermal expansion property when a negative thermal expansion material is added to a thermoplastic resin and heat-processed. The present invention provides a resin composition including metal oxide particles and a thermoplastic resin, both having a negative thermal expansion property. The negative thermal expansion of the particles is attributed to a crystal phase transition, which is driven by electron transfer between the constituent metals, and a covalent protective layer that inhibits the electron transfer is formed between the particles and the thermoplastic resin.
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Ito, Naoya
Abrégé
Provided are: a method for simply producing a tissue construct including a plurality of cell layers; and a method for effectively treating diseases by using the tissue construct. The method for producing a tissue construct comprises: a first preparation step for adding, into a tubular vessel with a bottom part, a suspension of first cells, which are cells among mesenchymal cells and epithelial cells; a first centrifugal step for subjecting the tubular vessel containing the suspension of the first cells to a first centrifugal treatment and forming a first cell layer on the bottom part via centrifugal force; a second preparation step for adding, onto the first cell layer in the tubular vessel, a suspension of second cells, which are the other cells among the mesenchymal cells and the epithelial cells; a second centrifugal step for subjecting the tubular vessel containing the suspension of the second cells to a second centrifugal treatment and forming a second cell layer on the first cell layer via centrifugal force; and a takeout step for taking out a tissue construct containing the first cell layer and the second cell layer from the tubular vessel.
A61L 27/40 - Matériaux composites, c.-à-d. en couches ou contenant un matériau dispersé dans une matrice constituée d'un matériau analogue ou différent
A61L 27/60 - Matériaux utilisables pour la peau artificielle
A61P 17/14 - Médicaments pour le traitement des troubles dermatologiques pour le traitement de la calvitie ou de l'alopécie
C12N 5/077 - Cellules mésenchymateuses, p. ex. cellules osseuses, cellules de cartilage, cellules stromales médulaires, cellules adipeuses ou cellules musculaires
44.
CELL TRANSPLANTING KIT, CELL TRANSPLANTING DEVICE, AND METHOD FOR TAKING IN TRANSPLANT
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Imai Keiichi
Fukuda Junji
Kageyama Tatsuto
Nanmo Ayaka
Abrégé
Provided is a cell transplanting kit including: a transplant containing a cell group; and a cell transplanting device. The cell transplanting device includes: a needle-like part that extends in a cylindrical shape and that has an opening at a distal-end section of the needle-like part; and a suction part that applies suction to the interior of the needle-like part. The needle-like part is configured so that the transplant can be taken into the interior thereof from the opening by drawing the transplant close thereto by means of the suction and is configured so that, in the state in which the transplant is taken in, the inner diameter of the needle-like part becomes smaller in an intermediate section between the distal end and a proximal end of the needle-like part. The suction part applies a suction pressure of -100 to -0.1 kPa, and the transplant includes a gel-like protective section that covers at least a portion of the cell group, wherein the outer diameter of the transplant is equal to or greater than the minimum value of the inner diameter of the needle-like part and the jelly strength of the protective section is equal to or greater than 100 g.
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
C12N 5/077 - Cellules mésenchymateuses, p. ex. cellules osseuses, cellules de cartilage, cellules stromales médulaires, cellules adipeuses ou cellules musculaires
A61B 17/00 - Instruments, dispositifs ou procédés chirurgicaux
A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (Japon)
THE KITASATO INSTITUTE (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Muraoka Takahiro
Yaguchi Atsuya
Ajioka Itsuki
Watanabe Go
Abrégé
The present invention addresses the problem of providing a peptide gelling agent that gelates under physiological conditions and has a relatively short chain length and a sustained release gel based on the same. Provided is a hydrogelling self-assembling peptide, the self-assembling peptide containing one or two core peptides comprising an amino acid sequence represented by the formula Xaa-Yaa-Zaa-Yaa-Xaa-Yaa-Zaa-Yaa-Xaa (in the formula, each Xaa independently is Ile or Met, each Yaa independently is Asp, Glu, Lys, or Arg, and each Zaa independently is Ala or Gly), and the total length of the amino acid sequence constituting the self-assembling peptide being no more than 25 amino acids.
A61K 38/00 - Préparations médicinales contenant des peptides
A61K 38/18 - Facteurs de croissanceRégulateurs de croissance
A61K 45/00 - Préparations médicinales contenant des ingrédients actifs non prévus dans les groupes
A61K 47/42 - ProtéinesPolypeptidesLeurs produits de dégradationLeurs dérivés p. ex. albumine, gélatine ou zéine
A61K 47/64 - Conjugués médicament-peptide, médicament-protéine ou médicament-acide polyaminé, c.-à-d. l’agent de modification étant un peptide, une protéine ou un acide polyaminé lié par covalence ou complexé à un agent thérapeutiquement actif
A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
A61P 9/10 - Médicaments pour le traitement des troubles du système cardiovasculaire des maladies ischémiques ou athéroscléreuses, p. ex. médicaments antiangineux, vasodilatateurs coronariens, médicaments pour le traitement de l'infarctus du myocarde, de la rétinopathie, de l'insuffisance cérébro-vasculaire, de l'artériosclérose rénale
A61P 25/00 - Médicaments pour le traitement des troubles du système nerveux
C07K 7/08 - Peptides linéaires ne contenant que des liaisons peptidiques normales ayant de 12 à 20 amino-acides
C07K 14/00 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés
C07K 14/475 - Facteurs de croissanceRégulateurs de croissance
C07K 14/50 - Facteur de croissance des fibroblastes [FGF]
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Nakajima Akira
Ito Takuro
Matsushita Sachiko
Isobe Toshihiro
Sunada Kayano
Abrégé
Provided are: a composite oxide ceramic having high antiviral activity; a functional material; and an article comprising the composite oxide ceramic and/or the functional material. A composite oxide ceramic according to one aspect of the present invention is a composite oxide ceramic containing cerium and molybdenum and having antiviral activity. A functional material according to one aspect of the present invention is a functional material prepared by mixing the composite oxide ceramic and a photocatalyst and/or a material having antimicrobial activity. An article according to one aspect of the present invention is an article having the composite oxide ceramic and/or the functional material on at least a part of the surface thereof.
A61L 2/23 - Procédés ou appareils de désinfection ou de stérilisation de matériaux ou d'objets autres que les denrées alimentaires ou les lentilles de contactAccessoires à cet effet utilisant des substances chimiques des substances solides, p. ex. des granules, des poudres, des blocs, des comprimés
C04B 35/495 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base d'oxydes à base d'oxydes de vanadium, de niobium, de tantale, de molybdène ou de tungstène ou de leurs solutions solides avec d'autres oxydes, p. ex. vanadates, niobates, tantalates, molybdates ou tungstates
C04B 35/50 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base de composés de terres rares
47.
Fluorescent member, its manufacturing method, and light-emitting apparatus
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Tatami, Junichi
Takahashi, Emi
Takahashi, Takuma
Abrégé
A fluorescent member according to present invention is composed of a sintered body for wavelength conversion containing a matrix containing magnesium oxide and magnesium hydroxide as main components, and phosphor particles dispersed in the matrix. A thermal conductivity of the fluorescent member is preferably 5 W/(m·K) or higher. A fluorescent member having both a satisfactory thermal conductivity and a satisfactory fluorescent property is provided without requiring a high-temperature sintering process (a high-temperature process at a temperature higher than 250° C.). Further, a method for manufacturing such a fluorescent member and a light-emitting apparatus using such a fluorescent member are provided.
C09K 11/77 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes contenant des métaux des terres rares
C09K 11/02 - Emploi de substances particulières comme liants, revêtements de particules ou milieux de suspension
H01L 33/50 - DISPOSITIFS À SEMI-CONDUCTEURS NON COUVERTS PAR LA CLASSE - Détails caractérisés par les éléments du boîtier des corps semi-conducteurs Éléments de conversion de la longueur d'onde
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
KEIO UNIVERSITY (Japon)
Inventeur(s)
Shimono Tomoyuki
Asai Hiroshi
Ohnishi Kouhei
Matsunaga Takuya
Kobayashi Hironao
Nakamura Masaya
Yagi Mitsuru
Abrégé
[Problem] To obtain information that more appropriately indicates the condition of an operation mechanism during an operation. [Solution] A medical device 1a, a medical device 1b, and a medical device 1c each comprise an operation mechanism 80, a slave-side actuator 212, a motion control unit 511, and a parameter acquisition unit 512. The operation mechanism 80 is a mechanism for operating on a patient. The slave-side actuator 212 causes the operation mechanism 80 to perform an operation. The motion control unit 511 calculates a control parameter relating to haptic sensation on the basis of information relating to position associated with the action of the slave-side actuator 212, and controls the motion of the slave-side actuator 212 for causing the operation mechanism 80 to perform the operation on the basis of the control parameter relating to the haptic sensation. The parameter acquisition unit 512 acquires the control parameter relating to the haptic sensation.
B25J 3/00 - Manipulateurs de type à commande asservie, c.-à-d. manipulateurs dans lesquels l'unité de commande et l'unité commandée exécutent des mouvements correspondants dans l'espace
49.
DRUG DELIVERY DEVICE AND METHOD FOR PRODUCING SAME
NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (Japon)
Inventeur(s)
Matsumoto Akira
Chen Siyuan
Miyazaki Takuya
Itoh Michiko
Suganami Takayoshi
Abrégé
The present invention provides a drug delivery device having a needle that has less influence on the drug delivery ability and has sufficient mechanical strength for puncture. A microneedle 10 has: a needle 110 capable of holding a drug and having drug permeability; and a soluble/degradable material layer 120 formed on at least a portion of the surface of the needle 110 and made of a material that dissolves or decomposes under physiological conditions.
A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Ajioka Itsuki
Oshikawa Mio
Muraoka Takahiro
Sawamoto Kazunobu
Kaneko Naoko
Abrégé
The present invention relates to a composition that is usable for sustained release of an active substance such as a functional protein. It was found that by using a composition which contains a self-assembling peptide and an active substance linked to the self-assembling peptide, it is possible to achieve sustained release of the active substance in vivo. By carrying out sustained release of an active substance such as a functional protein in vivo, it is possible to effectively induce angiogenesis and treat cerebral infarction. The composition which contains the self-assembling peptide and the active substance linked to the self-assembling peptide can be used, for example, for treatment of cerebral infarction.
A61K 47/64 - Conjugués médicament-peptide, médicament-protéine ou médicament-acide polyaminé, c.-à-d. l’agent de modification étant un peptide, une protéine ou un acide polyaminé lié par covalence ou complexé à un agent thérapeutiquement actif
A61K 38/00 - Préparations médicinales contenant des peptides
A61K 38/27 - Hormone de croissance [GH], c.-à-d. somatotropine
A61K 38/39 - Peptides du tissu connectif, p. ex. collagène, élastine, laminine, fibronectine, vitronectine, globuline insoluble à froid [CIG]
A61K 39/395 - AnticorpsImmunoglobulinesImmunsérum, p. ex. sérum antilymphocitaire
A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
KEIO UNIVERSITY (Japon)
Inventeur(s)
Shimono, Tomoyuki
Sasaki, Hikaru
Ohnishi, Kouhei
Shibao, Shunsuke
Mizoguchi, Takahiro
Matsunaga, Takuya
Abiko, Eriko
Nishimoto, Masaaki
Aoki, Mika
Abrégé
A medical gripping device includes a housing, a gripping mechanism at one end of the housing, an operation unit, and a reaction force actuator and a gripping actuator installed in the housing. The operation unit is operated by a gripping operation of an operator, and the reaction force actuator applies an operation reaction force to the operation unit. The gripping actuator causes the gripping mechanism to perform a gripping operation. A control unit controls a force and a position that are output by the gripping actuator in an operation of the gripping mechanism in accordance with an operation with respect to the operation unit, and controls a force and a position that are output by the reaction force actuator in an operation of applying the operation reaction force to the operation unit in accordance with a reaction from a gripped object with respect to the gripping mechanism.
METHOD FOR PRODUCING NEGATIVE THERMAL EXPANSION MATERIAL, METHOD FOR PRODUCING REACTION PRECURSOR OF NEGATIVE THERMAL EXPANSION MATERIAL, REACTION PRECURSOR OF NEGATIVE THERMAL EXPANSION MATERIAL, AND NEGATIVE THERMAL EXPANSION MATERIAL
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Azuma Masaki
Nishikubo Takumi
Matsuno Kana
Sakai Yuki
Poeppelmeier Kenneth
Paull Ryan J.
Abrégé
33, a portion of Bi is substituted by the rare-earth element or Sb and/or a portion of Ni is substituted by the metal capable of forming a trivalent ion.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Nakajima, Akira
Matsumoto, Takumi
Matsushita, Sachiko
Isobe, Toshihiro
Sunada, Kayano
Abrégé
A complex oxide ceramic according to an embodiment is a complex oxide ceramic including a rare earth element and at least one element selected from among molybdenum, tungsten, and vanadium. An example of the rare earth element is at least one species selected from among La, Ce, and Gd.
C04B 35/495 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base d'oxydes à base d'oxydes de vanadium, de niobium, de tantale, de molybdène ou de tungstène ou de leurs solutions solides avec d'autres oxydes, p. ex. vanadates, niobates, tantalates, molybdates ou tungstates
National University Corporation YOKOHAMA National University (Japon)
Kanagawa Institute of Industrial Science and Technology (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Abrégé
Provided are a cell-containing hydrogel body and a method of producing the same, which enable simple and effective control of the size of a boundary surface for an interaction between cells. The method of producing a cell-containing hydrogel body includes: forming, under a gas phase, a first hydrogel droplet on a surface of a substrate, the first hydrogel droplet containing first cells being dispersed therein and a first hydrogel polymer; forming, under a gas phase, a second hydrogel droplet on the surface, the second hydrogel droplet containing second cells being dispersed therein and a second hydrogel polymer, the second hydrogel droplet being combined with the first hydrogel droplet; and forming, under a gas phase, a cell-containing hydrogel body on the surface by gelling a hydrogel droplet-combined body including a first droplet portion derived from the first hydrogel droplet and a second droplet portion derived from the second hydrogel droplet.
C12N 5/00 - Cellules non différenciées humaines, animales ou végétales, p. ex. lignées cellulairesTissusLeur culture ou conservationMilieux de culture à cet effet
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
C12N 5/077 - Cellules mésenchymateuses, p. ex. cellules osseuses, cellules de cartilage, cellules stromales médulaires, cellules adipeuses ou cellules musculaires
C12N 11/04 - Enzymes ou cellules microbiennes immobilisées sur ou dans un support organique piégées à l’intérieur du support, p. ex. dans un gel ou dans des fibres creuses
C12N 11/098 - Enzymes ou cellules microbiennes immobilisées sur ou dans un support organique le support étant un polymère synthétique formé en présence des enzymes ou des cellules microbiennes
55.
ANTIGEN-BINDING MOLECULE, NUCLEIC ACID COMPOSITION, VECTOR COMPOSITION AND METHOD FOR PURIFYING CELLS AND BIFIDOBACTERIUM LONGUM
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
KEIO UNIVERSITY (Japon)
Inventeur(s)
Nakato Gaku
Inoue Joe
Inoue Hikaru
Fukuda Shinji
Abrégé
[Problem] To provide an antigen-binding molecule that has a high specificity to Bifidobacterium longum. [Solution] An antigen-binding molecule that binds to B. longum.
C07K 16/12 - Immunoglobulines, p. ex. anticorps monoclonaux ou polyclonaux contre du matériel provenant de bactéries
C12N 5/10 - Cellules modifiées par l'introduction de matériel génétique étranger, p. ex. cellules transformées par des virus
C12N 1/00 - Micro-organismes, p. ex. protozoairesCompositions les contenantProcédés de culture ou de conservation de micro-organismes, ou de compositions les contenantProcédés de préparation ou d'isolement d'une composition contenant un micro-organismeLeurs milieux de culture
C12N 1/15 - ChampignonsLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
C12N 1/19 - LevuresLeurs milieux de culture modifiés par l'introduction de matériel génétique étranger
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
JP STEEL PLANTECH CO. (Japon)
Inventeur(s)
Hosoi, Atsushi
Kawada, Hiroyuki
Harada, Kazuki
Jespersen, Kristine Munk
Abrégé
When there is thermal residual stress in a test piece obtained by joining different types of materials, a fracture toughness testing device 10 according to this invention is capable of evaluating the fracture toughness of the test piece in a pure mode in which the effect of the thermal residual stress has been removed. This fracture toughness testing device 10 comprises a testing load application means 17 for applying a prescribed testing load to a test piece 11 having thermal residual stress and a cancelling load application means 18 for applying a cancelling load to the test piece 11 so as to cancel the thermal residual stress of the test piece 11. The cancelling load application means 18 comprises a pressing force application unit 23 for operating so as to apply a pressing force to the test piece 11 as the cancelling load and a pressing force determination unit 24 for determining the magnitude of the pressing force. The pressing force determination unit 24 uses a formula that has been stored in advance to calculate a pressing force magnitude for making an energy release rate component corresponding to an in-plane-shear-type crack deformation state zero.
G01N 3/00 - Recherche des propriétés mécaniques des matériaux solides par application d'une contrainte mécanique
G01N 3/08 - Recherche des propriétés mécaniques des matériaux solides par application d'une contrainte mécanique par application d'efforts permanents de traction ou de compression
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Suganami, Takayoshi
Tanaka, Miyako
Matsumoto, Akira
Matsumoto, Hiroko
Morooka, Yuki
Miyahara, Yuji
Abrégé
A sugar-responsive gel that is highly resistant to temperature changes, and a sugar-responsive drug delivery device including such a gel. The sugar-responsive gel, which comprises a gel composition including a monomer having a hydroxyl group in addition to a phenylboronic-acid-based monomer, can exhibit suitable temperature resistance. A sugar-responsive drug delivery device including such a sugar-responsive gel is less susceptible to the effects of temperature changes, and therefore can prevent undesirable excessive delivery of a drug such as insulin.
A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
58.
Haptic transmission system, haptic transmission method, and program
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
KEIO UNIVERSITY (Japon)
Inventeur(s)
Shimono, Tomoyuki
Mizoguchi, Takahiro
Ohnishi, Kouhei
Tashiro, Tetsuya
Abrégé
A haptic transmission system includes a master device and a slave device. The master device controls position and force in an operation of the master device based on information acquired from the operation of the master device and information relating to a response of the slave device, and compensates for a communication delay in a communication path with respect to the control of force. The slave device controls speed and force in an operation of the slave device based on information acquired from the operation of the slave device and information relating to control from the master device.
B25J 3/00 - Manipulateurs de type à commande asservie, c.-à-d. manipulateurs dans lesquels l'unité de commande et l'unité commandée exécutent des mouvements correspondants dans l'espace
B25J 13/02 - Moyens de commande à préhension manuelle
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Yamada Tetsuya
Osaki Toshihisa
Mimura Hisatoshi
Sugiura Hirotaka
Takeuchi Shoji
Abrégé
This measurement instrument is provided with a first container and a second container arranged adjacent to each other and a partition wall that is provided between the first and second containers and has a through hole for forming a lipid bilayer membrane therein. A gas flow path having a hydrophobic surface is formed in at least one of the first and second containers. The gas flow path has an entrance and an exit, and the entrance and the exit each communicate with the exterior of the measurement instrument. The gas flow path opens within the container to which said gas flow path is provided. A gas flowing within the gas flow path is brought into contact with droplets with which the interior of the container is filled.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Maki, Hideyuki
Nakagawa, Kenta
Abrégé
A first metal film is formed on a substrate used in device production; a thin film of a solid carbon source is formed on the first metal film; a second metal film is formed on the thin film of a solid carbon source; and a laminate in which the first metal film, the thin film of a solid carbon source, and the second metal film are stacked in the stated order is subjected to heat treatment to grow graphene directly on the substrate.
H01L 31/10 - Dispositifs à semi-conducteurs sensibles aux rayons infrarouges, à la lumière, au rayonnement électromagnétique d'ondes plus courtes, ou au rayonnement corpusculaire, et spécialement adaptés, soit comme convertisseurs de l'énergie dudit rayonnement e; Procédés ou appareils spécialement adaptés à la fabrication ou au traitement de ces dispositifs ou de leurs parties constitutives; Leurs détails dans lesquels le rayonnement commande le flux de courant à travers le dispositif, p.ex. photo-résistances caractérisés par au moins une barrière de potentiel ou une barrière de surface, p.ex. photo-transistors
H01L 51/05 - Dispositifs à l'état solide qui utilisent des matériaux organiques comme partie active, ou qui utilisent comme partie active une combinaison de matériaux organiques et d'autres matériaux; Procédés ou appareils spécialement adaptés à la fabrication ou au traitement de tels dispositifs ou de leurs parties constitutives spécialement adaptés au redressement, à l'amplification, à la génération d'oscillations ou à la commutation et ayant au moins une barrière de potentiel ou une barrière de surface; Condensateurs ou résistances à l'état solide, ayant au moins une barrière de potentiel ou une barrière de surface
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Tatami Junichi
Torase Natsumi
Takahashi Takuma
Abrégé
In a fluorescent particle-dispersed glass (6) according to the present invention, glass is used as a matrix (3), and at least fluorescent particles (4) and a heat conductive filler (5) that includes boron nitride are dispersed in the matrix (3). The thermal conductivity of the fluorescent particle-dispersed glass (6) is preferably at least 2 W/(m·K) or higher. The boron nitride content is preferably 5 mass% or higher. Provided are a fluorescent particle-dispersed glass having both thermal conductivity and fluorescence, a method for producing the same, a light-emitting device, and a light-emitting system.
H01L 33/50 - DISPOSITIFS À SEMI-CONDUCTEURS NON COUVERTS PAR LA CLASSE - Détails caractérisés par les éléments du boîtier des corps semi-conducteurs Éléments de conversion de la longueur d'onde
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Kojima Takahiro
Azuma Masaki
Sakai Yuki
Abrégé
The purpose of the present invention is to obtain a resin composition having low thermal expansion by suppressing deterioration of a negative thermal expansion function when a negative thermal expansion material is added to a thermoplastic resin and heat-processed. The resin composition is characterized by comprising: metal oxide particles having negative thermal expansion; and a thermoplastic resin, wherein the negative thermal expansion of the particles is caused by a crystal phase transition, electron transfer between constituent metals is used as the driving force, and a covalent protective layer that inhibits electron transfer is formed between the particles and the thermoplastic resin.
C08L 101/12 - Compositions contenant des composés macromoléculaires non spécifiés caractérisées par des propriétés physiques, p. ex. anisotropie, viscosité ou conductivité électrique
G02B 1/04 - Éléments optiques caractérisés par la substance dont ils sont faitsRevêtements optiques pour éléments optiques faits de substances organiques, p. ex. plastiques
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
Inventeur(s)
Tatami Junichi
Takahashi Emi
Takahashi Takuma
Abrégé
This fluorescent member is a sintered body for wavelength conversion, which contains: a matrix comprising magnesium oxide and magnesium hydroxide as primary components; and fluorescent particles dispersed in the matrix. The thermal conductivity of the fluorescent member is preferably 5 W/(m·K) or more. Provided are: a fluorescent member that exhibits both thermal conductivity and fluorescence without the need for a high temperature firing process (a high temperature process in which the temperature exceeds 250°C); a method for producing same; and a light-emitting device.
C09K 11/02 - Emploi de substances particulières comme liants, revêtements de particules ou milieux de suspension
C09K 11/08 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes
C09K 11/64 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes contenant de l'aluminium
H01L 33/50 - DISPOSITIFS À SEMI-CONDUCTEURS NON COUVERTS PAR LA CLASSE - Détails caractérisés par les éléments du boîtier des corps semi-conducteurs Éléments de conversion de la longueur d'onde
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Maki, Hideyuki
Nakagawa, Kenta
Abrégé
Provided is a small-sized polarimetry device capable of high spatial resolution and temporal resolution. This polarimetry device has a nanocarbon light source for radiating polarized light to a sample, and a measurement instrument for measuring light transmitted, scattered, or reflected by the sample, the nanocarbon polarized light source having one or more carbon nanotubes, the major axis of which is oriented in a predetermined direction, and polarized light due to black-body radiation being directly outputted from the carbon nanotubes.
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Shimizu, Akihiro
Nakajima, Rikuma
Anakama, Riki
Abrégé
Provided are hair follicle primordia which can easily form a hair shaft-like structure in vitro in a short period of time. This method for producing hair follicle primordia includes forming hair follicle primordia by: seeding epithelial cells and mesenchymal cells; maintaining the epithelial cells and the mesenchymal cells in a culture solution in which (a) laminin and entactin, and/or (b) type IV collagen are dispersed; and co-culturing the epithelial cells and the mesenchymal cells in the culture solution.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
TORAY ENGINEERING CO., LTD. (Japon)
Inventeur(s)
Osaki, Toshihisa
Hayakawa, Masatoshi
Kamiya, Koki
Kaneko, Miharu
Uehara, Hideo
Araki, Katsufumi
Konda, Ayumi
Hirata, Hajime
Ura, Toshiyuki
Abrégé
Disclosed are a separator for lipid bilayer membrane formation capable of forming a lipid bilayer membrane with excellent properties, wherein the separator for lipid bilayer membrane formation has sufficient mechanical strength and can be easily manufactured in a large scale by using a general-purpose machine without need of using an expensive machine, and a method of producing the separator. The separator for lipid bilayer membrane formation includes a thin film having one or more through holes and made of a resin capable of being wet-etched, and reinforcing layers covering both surfaces of the thin film and made of a resin capable of being wet-etched. The reinforcing layers cover the whole area of the thin film, except for the through holes and the peripheries thereof, and each through hole has a tapered cross-sectional shape.
B32B 27/28 - Produits stratifiés composés essentiellement de résine synthétique comprenant des copolymères de résines synthétiques non complètement couverts par les sous-groupes suivants
B32B 38/10 - Enlèvement de couches ou de parties de couches, mécaniquement ou chimiquement
G03F 7/11 - Matériaux photosensibles caractérisés par des détails de structure, p. ex. supports, couches auxiliaires avec des couches de recouvrement ou des couches intermédiaires, p. ex. couches d'ancrage
G03F 7/00 - Production par voie photomécanique, p. ex. photolithographique, de surfaces texturées, p. ex. surfaces impriméesMatériaux à cet effet, p. ex. comportant des photoréservesAppareillages spécialement adaptés à cet effet
G03F 7/40 - Traitement après le dépouillement selon l'image, p. ex. émaillage
G03F 7/095 - Matériaux photosensibles caractérisés par des détails de structure, p. ex. supports, couches auxiliaires ayant plus d'une couche photosensible
B32B 38/00 - Opérations auxiliaires liées aux procédés de stratification
B32B 37/00 - Procédés ou dispositifs pour la stratification, p. ex. par polymérisation ou par liaison à l'aide d'ultrasons
G03F 7/42 - Élimination des réserves ou agents à cet effet
67.
FLUID SAMPLE INTERNAL STRUCTURE OBSERVATION DEVICE AND INTERNAL STRUCTURE ANALYSIS SYSTEM, FLUID SAMPLE INTERNAL STRUCTURE OBSERVATION METHOD AND INTERNAL STRUCTURE ANALYSIS METHOD, AND METHOD FOR MANUFACTURING CERAMIC
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
Inventeur(s)
Takahashi Takuma
Tatami Junichi
Takaba Hiroki
Abrégé
The present invention enables in-situ observation of structural changes occurring in a slurry in a shear field, in other words, enables an evaluation of the rheological properties of a slurry that includes a ceramic starting material, as a fluid sample, and enables in-situ simultaneous observation of the structure inside the fluid sample, and elucidation of changes in the internal structure thereof, in the course of the evaluation. A rheometer (10) is used to evaluate the rheological properties of a fluid sample (1) containing components having different refractive indexes, and an optical coherence tomographic image generating unit (20) is used to perform optical coherence tomographic imaging by radiating light in the infrared region onto the fluid sample (1) from outside the rheometer (10) to generate an optical coherence tomographic image, by tilting the optical axis of the light in the infrared region radiated onto the fluid sample (1) through a prescribed angle θ within an angle range of 1 to 10° relative to a normal line direction of an observation surface (1A) of the fluid sample (1), thereby making it possible to observe the structure inside the fluid sample (1) in the course of the evaluation of the rheological properties by means of the rheometer (10).
G01N 19/00 - Recherche sur les matériaux par des procédés mécaniques
G01N 21/17 - Systèmes dans lesquels la lumière incidente est modifiée suivant les propriétés du matériau examiné
G01N 11/14 - Recherche des propriétés d'écoulement des matériaux, p. ex. la viscosité, la plasticitéAnalyse des matériaux en déterminant les propriétés d'écoulement en déplaçant un corps à l'intérieur du matériau en utilisant des corps en rotation, p. ex. moulinet
68.
HAIR FOLLICLE GERMS, METHOD FOR PRODUCING HAIR FOLLICLE GERMS, AND METHOD FOR ACTIVATING CELLS INCLUDED IN HAIR FOLLICLE GERMS
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Tate, Yoshiki
Abrégé
Provided are hair follicle germs having excellent hair-growth related characteristics, a method for producing hair follicle germs, and a method for activating cells included in hair follicle germs. The hair follicle germs each include epithelial cells, mesenchymal cells, and mesenchymal stem cells. The method for producing hair follicle germs comprises forming hair follicle germs by co-culturing epithelial cells, mesenchymal cells, and mesenchymal stem cells.
C12N 15/12 - Gènes codant pour des protéines animales
C12Q 1/6809 - Méthodes de détermination ou d’identification des acides nucléiques faisant intervenir la détection différentielle
69.
METHOD FOR CULTURING MESENCHYMAL CELLS, METHOD FOR PRODUCING ACTIVATED MESENCHYMAL CELLS, METHOD FOR PRODUCING HAIR FOLLICLE PRIMORDIA, METHOD FOR ACTIVATING MESENCHYMAL CELLS, AND METHOD FOR ACTIVATING EPIDERMAL CELLS
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Yan, Lei
Zhang, Binbin
Abrégé
Provided are: a method for culturing mesenchymal cells whereby hair growth-related properties are improved; a method for producing activated mesenchymal cells; a method for producing hair follicle primordia; a method for activating mesenchymal cells; and a method for activating epidermal cells. The method for culturing mesenchymal cells comprises culturing mesenchymal cells, which are adhered to the surface of an electrode, while applying an electric current through the electrode. The method for producing activated mesenchymal cells comprises culturing mesenchymal cells, which are adhered to the surface of an electrode, while applying an electric current through the electrode to thereby give mesenchymal cells which are more activated compared to mesenchymal cells having been cultured in the same manner but no electric current is applied.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Takamizawa Satoshi
Takasaki Yuichi
Abrégé
The present invention provides a superelastic material which is characterized by containing a crystal of an oligomer. With respect to the superelastic material, it is preferable that the oligomer is a chain oligomer; and it is also preferable that the oligomer has an associating functional group. The present invention also provides an energy storage material, an energy absorption material, an elastic material, an actuator and a shape-memory material, each of which contains the above-described superelastic material.
C07C 53/126 - Acides contenant au moins cinq atomes de carbone
F03G 7/00 - Mécanismes produisant une puissance mécanique, non prévus ailleurs ou utilisant une source d'énergie non prévue ailleurs
F03G 7/06 - Mécanismes produisant une puissance mécanique, non prévus ailleurs ou utilisant une source d'énergie non prévue ailleurs utilisant la dilatation ou la contraction des corps produites par le chauffage, le refroidissement, l'humidification, le séchage ou par des phénomènes similaires
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Yamada, Tetsuya
Osaki, Toshihisa
Kamiya, Koki
Takeuchi, Shoji
Abrégé
Disclosed is an analyzing device which has a simple construction and excellent portability, which does not use a pump or external electric power, and with which a liquid used for measurement can be replaced. This analyzing device is provided with: a base plate; a detecting well provided in the base plate; a liquid storage well provided in the base plate; a liquid absorbent material disposed within the base plate; one or a plurality of first flow passages providing communication between the detecting well and the liquid storage well; and one or a plurality of second flow passages providing communication between the detecting well and the liquid absorbent material. Liquid introduced into the liquid storage well flows through the first flow passage, the detecting well, and the second flow passage, in this order, and reaches the liquid absorbent material, and at this time the flow rate of the liquid flowing into the detecting well and the flow rate of the liquid flowing out from the detecting well are substantially equal.
G01N 35/08 - Analyse automatique non limitée à des procédés ou à des matériaux spécifiés dans un seul des groupes Manipulation de matériaux à cet effet en utilisant un courant d'échantillons discrets circulant dans une canalisation, p. ex. analyse à injection dans un écoulement
G01N 35/10 - Dispositifs pour transférer les échantillons vers, dans ou à partir de l'appareil d'analyse, p. ex. dispositifs d'aspiration, dispositifs d'injection
G01N 37/00 - Détails non couverts par les autres groupes de la présente sous-classe
72.
COMPLEX OXIDE CERAMIC, METHOD FOR PRODUCING SAME, AND ARTICLE
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Nakajima Akira
Matsumoto Takumi
Matsushita Sachiko
Isobe Toshihiro
Sunada Kayano
Abrégé
A complex oxide ceramic according to one embodiment of the present invention contains a rare earth element and at least one element that is selected from among molybdenum, tungsten and vanadium. For example, the rare earth element is at least one element that is selected from among La, Ce and Gd.
C04B 35/50 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base de composés de terres rares
C04B 35/495 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base d'oxydes à base d'oxydes de vanadium, de niobium, de tantale, de molybdène ou de tungstène ou de leurs solutions solides avec d'autres oxydes, p. ex. vanadates, niobates, tantalates, molybdates ou tungstates
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KEIO UNIVERSITY (Japon)
Inventeur(s)
Shimono Tomoyuki
Sasaki Hikaru
Ohnishi Kouhei
Shibao Shunsuke
Mizoguchi Takahiro
Matsunaga Takuya
Abiko Eriko
Nishimoto Masaaki
Aoki Mika
Abrégé
[Problem] To realize a medical gripping device that can be used as forceps and has more functions than that of forceps. [Solution] In a medical gripping device 1, an operation unit 10 is operated by a gripping operation of an operator. A reaction force actuator 20 applies an operation reaction force to the operation unit 10. A gripping mechanism 40 grips an object to be gripped. A gripping actuator 50 causes the gripping mechanism 40 to perform a gripping operation. A housing 1A has a gripping mechanism 40 at one end and the operation unit 10 between the one end and the other end, and the reaction force actuator 20 and the gripping actuator 50 are installed therein. The control unit 60 controls the force and position outputted by the gripping actuator 50 in the operation of the gripping mechanism 40 in accordance with the operation on the operation unit 10, and also controls the force and position outputted by the reaction force actuator 20 in the operation of applying the operation reaction force to the operation unit 10 according to the reaction from the object to be gripped on the gripping mechanism 40.
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Abrégé
Provided are a cell-containing hydrogel body and a method for producing same, wherein the size of an interface for cell-cell interaction can be easily and effectively controlled. The method for producing a cell-containing hydrogel body comprises: forming a first hydrogel droplet in a gas phase on the surface of a substrate, the first hydrogel droplet containing dispersed first cells and a first hydrogel polymer; forming a second hydrogel droplet in a gas phase on the surface, the second hydrogel droplet being connected to the first hydrogel droplet and containing dispersed second cells and a second hydrogel polymer; and forming a cell-containing hydrogel body in a gas phase on the surface by gelling a hydrogel droplet connector including a first droplet portion derived from the first hydrogel droplet and a second droplet portion derived from the second hydrogel droplet.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Yoshimura, Chisa
Nakajima, Rikuma
Abrégé
[Problem] To provide: a color control method for regenerated hair which can control the color of hair simply and efficiently; a regeneration method for hair; and a method for producing hair follicle primordia. [Solution] This color control method for regenerated hair comprises: using source cells including epithelial stem cells obtained from adult hair follicle tissues containing a bulge region which is a constant part; mixing and culturing dispersed hair papilla cells and the dispersed source cells to prepare hair follicle primordia; and transplanting the hair follicle primordia into an animal to grow hair from the hair follicle primordia, wherein the weight ratio of a non-constant part which is included in the adult hair follicle tissues is changed to alter the color of hair grown from the hair follicle primordia.
A61P 17/14 - Médicaments pour le traitement des troubles dermatologiques pour le traitement de la calvitie ou de l'alopécie
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
C12N 5/071 - Cellules ou tissus de vertébrés, p. ex. cellules humaines ou tissus humains
76.
GLUCOSE REACTIVE COMPOSITE GEL COMPOSITION, METHOD FOR PRODUCING SAME, INSULIN DELIVERY MICRONEEDLE INCLUDING SAID GLUCOSE REACTIVE COMPOSITE GEL COMPOSITION, AND PRODUCING METHOD THEREFOR
NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Matsumoto, Akira
Chen, Siyuan
Abrégé
The present invention provides: a gel composition which can be preferably used for a microneedle that can release insulin in a self-regulated manner according to the concentration of glucose; and a microneedle using the same. An insulin delivery microneedle 1 has a base part 10 made from silk fibroin, at least one needle part 20 integrally provided on the base part 10, and an insulin reservoir 40. At least a tip portion of the needle part 20 comprises: a copolymer including a phenylboronic acid-based monomer unit; and a composite gel composition including a silk fibroin.
A61K 47/34 - Composés macromoléculaires obtenus par des réactions autres que celles faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. polyesters, acides polyaminés, polysiloxanes, polyphosphazines, copolymères de polyalkylène glycol ou de poloxamères
A61K 47/42 - ProtéinesPolypeptidesLeurs produits de dégradationLeurs dérivés p. ex. albumine, gélatine ou zéine
A61M 37/00 - Autres appareils pour introduire des agents dans le corpsPercutanisation, c.-à-d. introduction de médicaments dans le corps par diffusion à travers la peau
A61P 3/10 - Médicaments pour le traitement des troubles du métabolisme de l'homéostase du glucose de l'hyperglycémie, p. ex. antidiabétiques
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Kiyohara Hiroaki
Nagai Takayuki
Mawaribuchi Shuuji
Kumazawa Toshiaki
Abrégé
Provided is a novel polysaccharide composition that enhances the production, in Peyer's patches, of cytokines that promote bone marrow cell proliferation. The polysaccharide composition contains a polysaccharide obtained from soybeans, said polysaccharide having arabinogalactan as a main component and having a peak molecular weight in the range of 20,000 to 180,000.
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
A23K 10/30 - Produits alimentaires pour animaux à base de matières d’origine végétale, p. ex. de racines, de graines ou de foinProduits alimentaires pour animaux à base de matières d’origine fongique, p. ex. de champignons
A23L 33/105 - Extraits de plantes, leurs doublons artificiels ou leurs dérivés
A23L 33/125 - Modification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sirops d'hydrate de carboneModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des sucresModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des alcools de sucreModification de la qualité nutritive des alimentsProduits diététiquesLeur préparation ou leur traitement en utilisant des additifs contenant des hydrolysats d'amidon
A61K 36/48 - Fabaceae ou Leguminosae (famille du pois ou des légumineuses)CaesalpiniaceaeMimosaceaePapilionaceae
A61P 1/00 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KEIO UNIVERSITY (Japon)
Inventeur(s)
Shimono Tomoyuki
Mizoguchi Takahiro
Ohnishi Kouhei
Tashiro Tetsuya
Abrégé
In this haptic transmission system, a master device: controls position in an operation of the master device on the basis of information acquired from the operation of the master device and information relating to the response of a slave device; controls force in the operation of the master device on the basis of the information acquired from the operation of the master device and the information relating to the response of the slave device; and compensates for a communication delay in a communication path with respect to the control of force. The slave device: controls speed in an operation of the slave device on the basis of information acquired from the operation of the slave device and information relating to control from the master device; and controls force in the operation of the slave device on the basis of the information acquired from the operation of the slave device and the information relating to the control from the master device.
B25J 3/00 - Manipulateurs de type à commande asservie, c.-à-d. manipulateurs dans lesquels l'unité de commande et l'unité commandée exécutent des mouvements correspondants dans l'espace
79.
Electrolyte membrane and method for producing same
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Yamaguchi, Takeo
Oshiba, Yuhei
Ohashi, Hidenori
Tomatsu, Jin
Furuya, Koji
Ohno, Takao
Nanbu, Mami
Abrégé
2 or more, and an electrolyte containing a perfluorosulfonic acid polymer having an EW of 250 to 850 loaded into the pores of the microporous polyolefin membrane, wherein the membrane thickness of the composite membrane is 1 to 20 μm.
H01M 8/106 - Matériaux d’électrolyte polymère caractérisés par un support poreux n’ayant pas de propriétés conductrices ioniques caractérisés par la composition chimique du support poreux
H01M 8/1062 - Matériaux d’électrolyte polymère caractérisés par un support poreux n’ayant pas de propriétés conductrices ioniques caractérisés par les propriétés physiques du support poreux, p. ex. sa porosité ou son épaisseur
C25B 13/08 - DiaphragmesÉléments d'espacement caractérisés par le matériau à base de matériaux organiques
H01M 8/1025 - Matériaux d’électrolyte polymère caractérisés par la structure chimique de la chaîne principale du polymère conducteur ionique comprenant uniquement du carbone et de l’oxygène, p. ex. des polyéthers, des polyétheréthercétones sulfonés [S-PEEK], des polysaccharides sulfonés, des celluloses sulfonés ou des polyesters sulfonés
H01M 8/1039 - Matériaux d’électrolyte polymère halogénés, p. ex. des fluorures de polyvinylidène sulfonés
H01M 8/1081 - Matériaux d’électrolyte polymère caractérisés par le procédé de fabrication à partir de solutions, de dispersions ou de suspensions de polymères uniquement
H01M 8/1086 - Post-traitement de la membrane autrement que par polymérisation
H01B 1/12 - Conducteurs ou corps conducteurs caractérisés par les matériaux conducteurs utilisésEmploi de matériaux spécifiés comme conducteurs composés principalement d'autres substances non métalliques substances organiques
H01B 1/10 - Conducteurs ou corps conducteurs caractérisés par les matériaux conducteurs utilisésEmploi de matériaux spécifiés comme conducteurs composés principalement d'autres substances non métalliques sulfures
H01B 13/00 - Appareils ou procédés spécialement adaptés à la fabrication de conducteurs ou câbles
H01M 8/02 - Éléments à combustibleLeur fabrication Détails
C08J 9/42 - Imprégnation avec des composés macromoléculaires
H01B 1/06 - Conducteurs ou corps conducteurs caractérisés par les matériaux conducteurs utilisésEmploi de matériaux spécifiés comme conducteurs composés principalement d'autres substances non métalliques
H01M 8/10 - Éléments à combustible avec électrolytes solides
C25B 1/04 - Hydrogène ou oxygène par électrolyse de l'eau
C25B 9/73 - Assemblages comprenant plusieurs cellules du type filtre-presse
80.
METHOD FOR RECLAIMING TOOL MATERIAL AND TOOL MATERIAL
SUMITOMO HEAVY INDUSTRIES HIMATEX CO., LTD. (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Ishikawa Takeshi
Satuta Toshitaka
Takahashi Kazuhito
Yokota Tomohiro
Yoshida Kentaro
Nakamura Norio
Motoizumi Yu
Abrégé
Provided are a method for reclaiming tool material, as well as tool material manufactured by this method of reclamation, in which repair is performed by formation of a suitable overlay layer in any region of a high-speed tool steel base material. In particular, provided is a method for reclaiming tool material, which makes it possible to form a suitable overlay layer without producing peeling, cracking, or the like, even for a high-speed tool steel base material that has a rapidly-solidified structure. In order to solve the above problem, provided is a method for reclaiming tool material that is characterized by comprising a heat treatment step for heat-treating a high-speed tool steel base material at the temperature greater than 700°C and less than 825°C, and a repair overlay step for causing a repair overlay layer to form on a surface of the high-speed tool steel base material having undergone the heat treatment. The heat treatment temperature is preferably greater than 775°C and less than 825°C. The high-speed tool steel base material is preferably configured to be a high-speed tool steel laser overlay layer.
C21D 9/38 - Traitement thermique, p. ex. recuit, durcissement, trempe ou revenu, adapté à des objets particuliersFours à cet effet pour cylindres de laminoirs
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Hirano, Sugi
Abrégé
Provided are a method and kit which are for culturing hair follicle's epithelial stem cells and which can grow a large amount of hair follicle's epithelial stem cells with hair regeneration capability thereof maintained. This method for culturing hair follicle's epithelial stem cells, comprises a mass formation step for disseminating hair follicle's epithelial stem cells in a cell culture vessel, and allowing the hair follicle's epithelial stem cells to form a mass, a mixing step for adding an extracellular matrix component to the mass of the hair follicle's epithelial stem cells, to produce a mixture of the extracellular matrix component and the mass of the hair follicle's epithelial stem cells, and a culture step for adding a culture medium to the mixture, and performing culture. This kit for culturing hair follicle's epithelial stem cells comprises a cell culture vessel made of an oxygen-permeable material, an extracellular matrix component, and a culture medium.
SUMITOMO HEAVY INDUSTRIES HIMATEX CO., LTD. (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Ishikawa Takeshi
Satuta Toshitaka
Takahashi Kazuhito
Yokota Tomohiro
Yoshida Kentaro
Nakamura Norio
Motoizumi Yu
Abrégé
Provided is a method for efficiently improving other mechanical properties (bending stress, toughness, impact resistance, etc.) without significantly impairing the wear resistance and high-temperature softening resistance, etc. of a buildup layer formed by the laser cladding method. In addition, the present invention provides a tool material in which a buildup layer of high-speed tool steel having excellent bending stress, toughness, impact resistance, wear resistance, etc. is formed on the outermost surface of a relatively inexpensive metal substrate. This is achieved by providing a tool material manufacturing method comprising: a laser cladding step of supplying high-speed tool steel powder to the surface of a metal base while irradiating with a laser beam, a spheroidizing annealing step of heat treating the buildup layer at 750°C-880°C, a quenching step of quenching the buildup layer subjected to the spheroidizing annealing step, and a tempering step of tempering the buildup layer subjected to the quenching step.
C21D 9/38 - Traitement thermique, p. ex. recuit, durcissement, trempe ou revenu, adapté à des objets particuliersFours à cet effet pour cylindres de laminoirs
B23P 15/28 - Fabrication d'objets déterminés par des opérations non couvertes par une seule autre sous-classe ou un groupe de la présente sous-classe d'outils de coupe
83.
PARTITION WALL FOR FORMATION OF LIPID BILAYER MEMBRANE, AND METHOD FOR PRODUCING SAME
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
TORAY ENGINEERING CO., LTD. (Japon)
Inventeur(s)
Osaki, Toshihisa
Hayakawa, Masatoshi
Kamiya, Koki
Kaneko, Miharu
Uehara, Hideo
Araki, Katsufumi
Konda, Ayumu
Hirata, Hajime
Ura, Toshiyuki
Abrégé
Disclosed are: a partition wall for the formation of a lipid bilayer membrane, which makes it possible to form a good lipid bilayer membrane, while having sufficient mechanical strength, and which is able to be easily mass produced with use of a common apparatus without requiring an expensive apparatus; and a method for producing this partition wall for the formation of a lipid bilayer membrane. A partition wall for the formation of a lipid bilayer membrane according to the present invention is provided with: a thin film which has one or more through holes and is formed from a wet etchable resin; and reinforcing layers which cover the both surfaces of the thin film and are formed from a wet etchable resin. The reinforcing layers cover portions other than the through holes and the portions around the through holes; and each through hole has a tapered cross-sectional shape.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
Inventeur(s)
Takahashi, Takuma
Tatami, Junichi
Kokubun, Ippei
Yokouchi, Masahiro
Abrégé
A nitride phosphor particle dispersion-type sialon ceramic of the present invention includes a matrix formed of a sialon-based compound; and at least one nitride phosphor which is dispersed in the matrix and contains a luminescence center element.
C09K 11/64 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes contenant de l'aluminium
C09K 11/00 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes
C09K 11/08 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes
C09K 11/77 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes contenant des métaux des terres rares
C09K 11/02 - Emploi de substances particulières comme liants, revêtements de particules ou milieux de suspension
C04B 35/581 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base de non oxydes à base de borures, nitrures ou siliciures à base de nitrure d'aluminium
C04B 35/584 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base de non oxydes à base de borures, nitrures ou siliciures à base de nitrure de silicium
C04B 35/63 - Préparation ou traitement des poudres individuellement ou par fournées utilisant des additifs spécialement adaptés à la formation des produits
85.
Regenerated hair follicle primordium aggregation manufacturing method, hair follicle tissue-containing sheet, and method for manufacturing hair follicle tissue-containing sheet
Kanagawa Institute of Industrial Science and Technology (Japon)
Inventeur(s)
Fukuda, Junji
Kageyama, Tatsuto
Yoshimura, Chisa
Onishi, Kisaki
Abrégé
The present invention provides a method for manufacturing a regular and high-density regenerated hair follicle primordium aggregation similar to the hair follicle tissue of a mammal in a simple manner. A regenerated hair follicle primordium aggregation manufacturing method of the present invention includes a step of forming hair follicle primordia by inoculating a microwell plate, which includes regularly arranged microwell portions, with mesenchymal cells and epithelial cells and culturing a mixture of the cells while supplying oxygen thereto.
A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
YOKOHAMA NATIONAL UNIVERSITY (Japon)
KEIO UNIVERSITY (Japon)
Inventeur(s)
Mizoguchi, Takahiro
Shimono, Tomoyuki
Ohnishi, Kouhei
Abrégé
Provided is a forceps system which is simple, can be used with the same sensation as conventional forceps systems, and has excellent operability. This forceps system is equipped with a head part having a first rotary motor and a second rotary motor, a manipulation part pivotally supported on the head part and coupled to the first rotary motor via a power transmission mechanism, a shaft part attached to the head part, a grasping part disposed on the distal end of the shaft part and for pinching a target, a manipulation member passing through the shaft part and having one end thereof coupled to the grasping part via a link mechanism and the other end thereof coupled to the second rotary motor via a power transmission mechanism, and a control unit controlling the first rotary motor and the second rotary motor. The control unit uses acceleration-based bilateral control to control the angular response of the first rotary motor and the second rotary motor in accordance with the angle deviation between the first rotary motor and the second rotary motor, and to control the torque response of the first rotary motor and the second rotary motor in accordance with the torque deviation between the first rotary motor and the second rotary motor.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
G-QUEST CO., LTD. (Japon)
Inventeur(s)
Fujii Hisashi
Rachi Takeshi
Odashiro Ken
Abrégé
Provided are a temperature measurement method, temperature measurement tool, and temperature measurement device that do not require wiring or other supplementary items, can be used in a conveyance-type or sealed-type heat treatment furnace, and make it possible to simply and accurately measure a maximum temperature and temperature distribution within a wide temperature range of approximately 200-1000°C. In the present invention, it is possible to accurately estimate a maximum temperature through the use of the property of a tin oxide film or indium oxide film including an n-type impurity or n-type and p-type impurities in terms of an electrical resistance value thereof changing irreversibly according to its history of temperatures.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Kiyohara, Akihiro
Nagai, Takayuki
Mawaributi, Syuji
Kumazawa, Toshiaki
Abrégé
The present invention provides a composition for activating Peyer's patch. More specifically, the present invention relates to a polysaccharide composition containing a polysaccharide produced from roasted or unroasted sesame seeds or sesame oil squeeze draff, said polysaccharide composition being characterized in that the polysaccharide produced from roasted sesame seeds or sesame oil squeeze draff contains a heteroglycan as a main component and has a peak molecular weight of 10,000 to 100,000 and the polysaccharide produced from unroasted sesame seeds or sesame oil squeeze draff contains a heteroglycan as a main component and has a peak molecular weight of 500,000 to 1,600,000.
A61K 31/715 - Polysaccharides, c.-à-d. ayant plus de cinq radicaux saccharide liés les uns aux autres par des liaisons glycosidiquesLeurs dérivés, p. ex. éthers, esters
A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
A61K 131/00 - Parties de plantes contenant des graines ou des semences, des noix ou des noisettes, des fruits ou des grains, ou obtenues à partir de ces éléments
89.
METHOD FOR OBSERVING INNER STRUCTURE OF CERAMIC, METHOD FOR PRODUCING CERAMIC, ANALYSIS SYSTEM, AND SYSTEM FOR PRODUCING CERAMIC
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
Inventeur(s)
Takahashi Takuma
Tatami Junichi
Abrégé
This method for observing the inner structure of ceramic using optical coherence tomography includes: a step for dividing light in the infrared region into a reference light and an irradiation light; a step for irradiating the ceramic with the irradiation light; and a step for observing the inner structure of the ceramic by observing the coherency between the reflected reference light and returning light obtained by irradiating the ceramic with the irradiation light.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fujii, Satoshi
Kamiya, Koki
Osaki, Toshihisa
Misawa, Norio
Takeuchi, Shoji
Abrégé
[Problem] To provide a method for detecting a nucleic acid, whereby it becomes possible to detect a nucleic acid such as miRNA within a short time and in a nucleotide sequence-specific manner without requiring the use of an expensive apparatus. [Solution] A method for detecting a target nucleic acid having a specific nucleotide sequence in a sample comprises: a double-stranded nucleic acid formation step of hybridizing the target nucleic acid with a liposome-bonded single-stranded nucleic acid to form a double-stranded nucleic acid, wherein the liposome-bonded single-stranded nucleic acid is composed of a labeled liposome bonded to a single-stranded nucleic acid, is immobilized onto a support or is so modified as to be capable of being immobilized onto a support, and contains a nucleotide sequence complementary to the target nucleic acid; a liposome liberation step of allowing a double-strand-specific nuclease to act on the formed double-stranded nucleic acid to cleave the nucleic acid and thereby liberate the liposome; and a label detection step of detecting a label in the liberated liposome.
C12Q 1/68 - Procédés de mesure ou de test faisant intervenir des enzymes, des acides nucléiques ou des micro-organismesCompositions à cet effetProcédés pour préparer ces compositions faisant intervenir des acides nucléiques
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
Inventeur(s)
Takahashi Takuma
Tatami Junichi
Kokubun Ippei
Yokouchi Masahiro
Abrégé
This nitride phosphor particle dispersion-type sialon ceramic includes: a matrix comprising a sialon compound; and at least one nitride phosphor containing a luminescence center element, the nitride phosphor being dispersed in the matrix.
C09K 11/08 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes
C09K 11/00 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes
C09K 11/64 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes contenant de l'aluminium
C09K 11/80 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes contenant des métaux des terres rares contenant de l'aluminium ou du gallium
92.
Crystal oriented ceramicscrystal oriented ceramics, the production process, and heat radiation material
Kanagawa Institute of Industrial Science and Technology (Japon)
Inventeur(s)
Takahashi, Takuma
Tatami, Junichi
Sugimoto, Nanako
Abrégé
A production process for a crystal oriented ceramics includes: a first step of preparing composite particles formed of particles having magnetic anisotropy having magnetic susceptibility anisotropy and seed particles having magnetic susceptibility anisotropy less than or equal to 1/10 of the magnetic susceptibility anisotropy of the particles having magnetic anisotropy and are formed of an inorganic compound having an anisotropic shape in which a crystal axis intended to be corresponds to a minor axis or a major axis; a second step of adding raw material powder including the composite particles to a solvent to prepare a slurry a third step of preparing a green compact by disposing the slurry in a static magnetic field of ≥0.1 tesla and drying the slurry in a state in which crystal axes of the seed particles in a major axis direction are in one direction; and a fourth step of sintering the green compact.
C04B 35/10 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base d'oxydes à base d'oxyde d'aluminium
C09K 5/14 - Substances solides, p. ex. pulvérulentes ou granuleuses
C04B 35/584 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base de non oxydes à base de borures, nitrures ou siliciures à base de nitrure de silicium
C04B 35/63 - Préparation ou traitement des poudres individuellement ou par fournées utilisant des additifs spécialement adaptés à la formation des produits
C04B 35/80 - Fibres, filaments, "whiskers", paillettes ou analogues
H01F 1/11 - Aimants ou corps magnétiques, caractérisés par les matériaux magnétiques appropriésEmploi de matériaux spécifiés pour leurs propriétés magnétiques en matériaux inorganiques caractérisés par leur coercivité en matériaux magnétiques durs substances non métalliques, p. ex. ferrites sous forme de particules
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Yamaguchi, Takeo
Oshiba, Yuhei
Ohashi, Hidenori
Tomatsu, Jin
Furuya, Koji
Ohno, Takao
Nanbu, Mami
Abrégé
Provided is an electrolyte membrane exhibiting high proton conductivity even in low humidity. The electrolyte membrane comprises a composite membrane provided with a polyolefin microporous membrane that has an average pore size of 1 to 1000 nm and a porosity of 50 to 90% and that can be impregnated with a solvent having a surface free energy of 28 mJ/m2 or higher, and an electrolyte containing EW250-850 perfluorosulfonic acid polymer packed into the pores of the polyolefin microporous membrane, the thickness of the composite membrane being 1 to 20 μm.
H01M 8/02 - Éléments à combustibleLeur fabrication Détails
C08J 9/42 - Imprégnation avec des composés macromoléculaires
H01B 1/06 - Conducteurs ou corps conducteurs caractérisés par les matériaux conducteurs utilisésEmploi de matériaux spécifiés comme conducteurs composés principalement d'autres substances non métalliques
H01B 1/10 - Conducteurs ou corps conducteurs caractérisés par les matériaux conducteurs utilisésEmploi de matériaux spécifiés comme conducteurs composés principalement d'autres substances non métalliques sulfures
H01B 1/12 - Conducteurs ou corps conducteurs caractérisés par les matériaux conducteurs utilisésEmploi de matériaux spécifiés comme conducteurs composés principalement d'autres substances non métalliques substances organiques
H01B 13/00 - Appareils ou procédés spécialement adaptés à la fabrication de conducteurs ou câbles
H01M 8/10 - Éléments à combustible avec électrolytes solides
94.
CELL-EMBEDDED BEADS FOR HAIR REGENERATION AND METHOD FOR PRODUCING SAME, AND KIT FOR HAIR REGENERATION
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Fukuda Junji
Kageyama Tatsuto
Abrégé
Provided are cell-embedded beads for hair regeneration having high hair-regenerating activity, and a method for producing the same. The cell-embedded beads for hair regeneration contain mesenchymal cells and biocompatible hydrogel. The method for producing cell-embedded beads for hair regeneration is a method provided with a cell-embedded cured gel formed body preparation step that prepares liquid droplets containing mesenchymal cells and biocompatible hydrogel, cures the biocompatible hydrogel, and prepares a cell-embedded cured gel formed body, and an aggregation step that suspension cultures the cell-embedded cured gel formed body and induces aggregation by the tractive force of the cells.
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Hayakawa Masatoshi
Osaki Toshihisa
Kamiya Koki
Fujii Satoshi
Takeuchi Shoji
Abrégé
[Problem] To more accurately measure the ion channel current of an ion-permeable lipid bilayer membrane. [Solution] This method for forming an ion-permeable lipid bilayer membrane is provided with: a step S501 for placing, on an electrode base, a plate that has on the upper surface thereof at least a pair of wells capable of holding a liquid therein, the wells being disposed so that the pair of wells communicate to each other, and bringing at least a pair of electrodes communicating the interior of the wells and the bottom surface of the plate to each other and at least a pair of contacts provided to the electrode base into contact with each other; a step S502 for fixing the plate and the electrode base, using an urging means for urging the contacts towards the electrodes and a fixing means for fixing the plate and the electrode base, so that the electrodes and the contacts are in contact with each other; a step S503 for forming a lipid bilayer membrane; and a step S504 for applying a constant voltage between the pair of electrodes and measuring the current between the pair of electrodes using an ammeter.
B01J 19/00 - Procédés chimiques, physiques ou physico-chimiques en généralAppareils appropriés
G01N 27/06 - Recherche ou analyse des matériaux par l'emploi de moyens électriques, électrochimiques ou magnétiques en recherchant l'impédance en recherchant la résistance d'un liquide
C12M 1/00 - Appareillage pour l'enzymologie ou la microbiologie
96.
Memory circuit with a bistable circuit and a non-volatile element
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
Inventeur(s)
Sugahara, Satoshi
Shuto, Yusuke
Yamamoto, Shuichiro
Abrégé
A memory circuit includes: cells arranged in rows and columns so that the rows are grouped to form banks each including one or more rows, each cell including: a bistable circuit storing data; and a non-volatile element storing data stored in the bistable circuit in a non-volatile manner and restoring data stored in a non-volatile manner to the bistable circuit; and a controller that performs a store operation on each row in turn; sets a voltage supplied, as a power-supply voltage, to cells in a first bank, which includes a row on which the store operation is performed, of the banks to a first voltage; and sets a voltage supplied, as a power-supply voltage, to cells in a bank of the banks other than the first bank to a second voltage that is less than the first voltage but at which data in the bistable circuit is retained.
G11C 11/00 - Mémoires numériques caractérisées par l'utilisation d'éléments d'emmagasinage électriques ou magnétiques particuliersÉléments d'emmagasinage correspondants
G11C 14/00 - Mémoires numériques caractérisées par des dispositions de cellules ayant des propriétés de mémoire volatile et non volatile pour sauvegarder l'information en cas de défaillance de l'alimentation
G11C 11/16 - Mémoires numériques caractérisées par l'utilisation d'éléments d'emmagasinage électriques ou magnétiques particuliersÉléments d'emmagasinage correspondants utilisant des éléments magnétiques utilisant des éléments dans lesquels l'effet d'emmagasinage est basé sur l'effet de spin
97.
METHOD FOR MEASURING HEAT HISTORY, IMPLEMENT FOR MEASURING HEAT HISTORY, AND DEVICE FOR MEASURING HEAT HISTORY
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
G-QUEST CO., LTD. (Japon)
Inventeur(s)
Fujii Hisashi
Rachi Takeshi
Odashiro Ken
Abrégé
A method for measuring a heat history, an implement for measuring a heat history, and a device for measuring a heat history, which can be used in a conveying-type or hermetically-sealed-type heat-treat furnace without wires, etc., and can be used to make simple and accurate measurements of the heating temperature and heating time over a wide temperature region, which is approximately 300−1000˚C. It is possible to estimate the heating temperature and heating time by utilizing a phenomenon in which the transmittance of an impurity-doped tin oxide film in the visible to near-infrared region changes irreversibly with respect to the received heat history.
G01K 11/12 - Mesure de la température basée sur les variations physiques ou chimiques, n'entrant pas dans les groupes , , ou utilisant le changement de couleur, de translucidité ou de réflectance
98.
Transparent fluorescent sialon ceramic and method of producing same
C09K 11/77 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes contenant des métaux des terres rares
C04B 35/597 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base de non oxydes à base de borures, nitrures ou siliciures à base d'oxynitrures de silicium
C04B 35/626 - Préparation ou traitement des poudres individuellement ou par fournées
C04B 35/63 - Préparation ou traitement des poudres individuellement ou par fournées utilisant des additifs spécialement adaptés à la formation des produits
C09K 11/02 - Emploi de substances particulières comme liants, revêtements de particules ou milieux de suspension
C09K 11/08 - Substances luminescentes, p. ex. électroluminescentes, chimiluminescentes contenant des substances inorganiques luminescentes
H01L 33/50 - DISPOSITIFS À SEMI-CONDUCTEURS NON COUVERTS PAR LA CLASSE - Détails caractérisés par les éléments du boîtier des corps semi-conducteurs Éléments de conversion de la longueur d'onde
99.
CERAMIC INCLUDING ALIGNED CRYSTALS, PRODUCTION PROCESS THEREFOR, AND HEAT RADIATION MATERIAL
KANAGAWA INSTITUTE OF INDUSTRIAL SCIENCE AND TECHNOLOGY (Japon)
NATIONAL UNIVERSITY CORPORATION YOKOHAMA NATIONAL UNIVERSITY (Japon)
Inventeur(s)
Takahashi Takuma
Tatami Junichi
Sugimoto Nanako
Abrégé
This process for producing a ceramic including aligned crystals comprises: a first step in which composite particles (C) comprising magnetically anisotropic particles (A) having anisotropy in magnetic susceptibility and seed particles (B) are formed, the seed particles (B) having anisotropy in magnetic susceptibility not greater than 1/10 that of the magnetically anisotropic particles (A) and comprising an inorganic compound of an anisotropic shape in which the crystal axis to be aligned corresponds to the minor axis or major axis; a second step in which a starting-material powder (D) comprising the composite particles (C) is added to a solvent to prepare a slurry comprising the starting-material powder (D) and the solvent; a third step in which the slurry is placed in a static magnetic field with 0.1 tesla (T) or greater, the major-axis-direction crystal axes of the seed particles (B) are unidirectionally aligned, and the slurry is dried in such state, thereby forming a molded object; and a fourth step in which the molded object is sintered.
C04B 35/622 - Procédés de mise en formeTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques
C04B 35/10 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base d'oxydes à base d'oxyde d'aluminium
C04B 35/584 - Produits céramiques mis en forme, caractérisés par leur compositionCompositions céramiquesTraitement de poudres de composés inorganiques préalablement à la fabrication de produits céramiques à base de non oxydes à base de borures, nitrures ou siliciures à base de nitrure de silicium
100.
Method of manufacturing mold, and molded article having fine relief structure on surface and method of manufacturing the same